# Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

> **NCT00312169** · — · COMPLETED · sponsor: **Orlando Immunology Center** · enrollment: 20 (estimated)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00312169
- **Lead sponsor:** Orlando Immunology Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312169, "Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00312169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*